News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mayne Pharma.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Ansell gloves up for Trump tariff threat
Health & Biotech
Health Check: Mayne Pharma and Acrux are on a drug expansion drive, generically speaking
News
Closing Bell: ASX pops on tech, banks, goldies and possible China ‘bazooka style’ stimulus
News
ASX Small Caps Lunch Wrap: ASX spikes as gold stocks rally; Equinox surges on antimony finds
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
News
Closing Bell: Desert Metals up 127pc… but where was the ASX on Day 1 of Spring?
News
Rise and Shine: Everything you need to know before the market opens
News
CLOSING BELL: Back from the dead, the ASX delivers in a George A Romero slow-zombie classic
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
Health & Biotech
ASX Health Stocks: Mayne Pharma launches women contraceptives in US, Oventus’ administrators take over
News
Market Highlights: Another rally before crucial CPI report; and 5 ASX small caps to watch on Thursday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks dancing to a positive tune
Experts
ScoPo’s Powerplays: Calmer week for ASX health stocks with some alarming stats about how many people drink instant coffee
News
Market highlights and 5 ASX small caps to watch on Friday
Experts
ScoPo’s Powerplays: Taps on again with ASX health stocks in BIG capital raises
News
Top 10 at 10: The ASX stocks winning and wilting in early trade Wednesday
News